Endra Life Sciences Inc (NDRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 357 | 762 | 794 | 1,809 | 2,065 |
| TOTAL | $537 | $968 | $1,049 | $1,853 | $2,180 |
| Non-Current Assets | |||||
| PPE Net | 33 | 43 | 53 | 63 | 73 |
| Other Non-Current Assets | 2,869 | 2,843 | 863 | 891 | 918 |
| TOTAL | $2,902 | $2,886 | $915 | $955 | $990 |
| Total Assets | $3,438 | $3,854 | $1,964 | $2,808 | $3,171 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 702 | 622 | 672 | 448 | 440 |
| TOTAL | $835 | $751 | $800 | $577 | $566 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 816 | 843 | 992 | 758 | 852 |
| TOTAL | $816 | $843 | $992 | $758 | $852 |
| Total Liabilities | $1,651 | $1,594 | $1,793 | $1,335 | $1,418 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,270 | 1,241 | 1,166 | 753 | 738 |
| Retained earnings | -111,777 | -110,466 | -107,296 | -105,700 | -104,474 |
| TOTAL | $1,787 | $2,260 | $171 | $1,473 | $1,753 |
| Total Liabilities And Equity | $3,438 | $3,854 | $1,964 | $2,808 | $3,171 |